Valentina Viggiani

520 total citations
17 papers, 359 citations indexed

About

Valentina Viggiani is a scholar working on Reproductive Medicine, Surgery and Oncology. According to data from OpenAlex, Valentina Viggiani has authored 17 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Reproductive Medicine, 4 papers in Surgery and 4 papers in Oncology. Recurrent topics in Valentina Viggiani's work include Ovarian cancer diagnosis and treatment (8 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Endometriosis Research and Treatment (3 papers). Valentina Viggiani is often cited by papers focused on Ovarian cancer diagnosis and treatment (8 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Endometriosis Research and Treatment (3 papers). Valentina Viggiani collaborates with scholars based in Italy and India. Valentina Viggiani's co-authors include Emanuela Anastasi, Luigi Frati, M. G. Reale, Teresa Granato, Antonio Angeloni, C Midulla, Lucia Manganaro, Flavia Longo, Maria Grazia Porpora and Piero Chirletti and has published in prestigious journals such as PLoS ONE, International Journal of Environmental Research and Public Health and Clinica Chimica Acta.

In The Last Decade

Valentina Viggiani

17 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Valentina Viggiani Italy 9 217 80 80 79 65 17 359
Angèle L.M. Oei Netherlands 7 176 0.8× 55 0.7× 75 0.9× 99 1.3× 44 0.7× 16 368
Andrea Puppo Italy 10 108 0.5× 78 1.0× 71 0.9× 91 1.2× 142 2.2× 30 362
Lirong Zhu China 11 154 0.7× 44 0.6× 52 0.7× 108 1.4× 90 1.4× 24 330
G. C. Torre Italy 5 153 0.7× 78 1.0× 104 1.3× 69 0.9× 56 0.9× 8 325
Takuhei Yokoyama Japan 11 141 0.6× 40 0.5× 174 2.2× 117 1.5× 107 1.6× 17 399
Viola Ghizzoni Italy 9 136 0.6× 22 0.3× 75 0.9× 112 1.4× 129 2.0× 27 303
Daniela Freitas Brazil 9 111 0.5× 121 1.5× 68 0.8× 95 1.2× 158 2.4× 24 368
Alberto Villanueva Spain 8 131 0.6× 67 0.8× 176 2.2× 163 2.1× 46 0.7× 12 419
Rosemary Lord United Kingdom 11 128 0.6× 44 0.6× 119 1.5× 182 2.3× 84 1.3× 34 396
Heng Cui China 15 394 1.8× 84 1.1× 94 1.2× 67 0.8× 215 3.3× 47 545

Countries citing papers authored by Valentina Viggiani

Since Specialization
Citations

This map shows the geographic impact of Valentina Viggiani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valentina Viggiani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valentina Viggiani more than expected).

Fields of papers citing papers by Valentina Viggiani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Valentina Viggiani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valentina Viggiani. The network helps show where Valentina Viggiani may publish in the future.

Co-authorship network of co-authors of Valentina Viggiani

This figure shows the co-authorship network connecting the top 25 collaborators of Valentina Viggiani. A scholar is included among the top collaborators of Valentina Viggiani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valentina Viggiani. Valentina Viggiani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Filardi, Tiziana, Valentina Viggiani, Paola Galoppi, et al.. (2025). Association of Circulating GDF-15 with Fetal Growth in Gestational Diabetes. Journal of Clinical Medicine. 14(8). 2764–2764. 1 indexed citations
2.
Molfino, Alessio, Emanuela Anastasi, Giovanni Imbimbo, et al.. (2024). Association between serum levels of GDF-15, suPAR, PIVKA-II, sdLDL and clinical outcomes in hospitalized COVID-19 patients. Internal and Emergency Medicine. 19(6). 1557–1566. 4 indexed citations
3.
Farina, Antonella, Valentina Viggiani, Francesca Cortese, et al.. (2024). Combined PIVKA II and Vimentin-Guided EMT Tracking in Pancreatic Adenocarcinoma Combined Biomarker-Guided EMT Tracking in PDAC. Cancers. 16(13). 2362–2362. 2 indexed citations
4.
Anastasi, Emanuela, Valentina Viggiani, Maria Grazia Piccioni, et al.. (2023). Efficacy of N-Acetylcysteine on Endometriosis-Related Pain, Size Reduction of Ovarian Endometriomas, and Fertility Outcomes. International Journal of Environmental Research and Public Health. 20(6). 4686–4686. 19 indexed citations
5.
Manganaro, Lucia, Valentina Viggiani, Teresa Granato, et al.. (2022). CT imaging phenotypes linked to CA125 and HE4 biomarkers are highly predictive in discriminating between hereditary and sporadic ovarian cancer patients. Tumor Biology. 44(1). 171–185. 2 indexed citations
6.
Farina, Antonella, Cristiano Ialongo, Valentina Viggiani, et al.. (2021). Transient plasma cell dyscrasia in COVID-19 patients linked to IL-6 triggering. Microbes and Infection. 23(4-5). 104808–104808. 7 indexed citations
7.
Mancini, Patrizia, et al.. (2021). PIVKA-II: A biomarker for diagnosing and monitoring patients with pancreatic adenocarcinoma. PLoS ONE. 16(5). e0251656–e0251656. 12 indexed citations
8.
Granato, Teresa, Emanuela Anastasi, Antonio Angeloni, et al.. (2019). Protein Induced by Vitamin K Absence II (PIVKA-II) as a potential serological biomarker in pancreatic cancer: a pilot study. Biochemia Medica. 29(2). 352–358. 17 indexed citations
9.
Manganaro, Lucia, Martina Di Trani, Valentina Viggiani, et al.. (2019). Evaluation of CA125 and HE4 diagnostic performance in hereditary and sporadic ovarian cancer. Clinica Chimica Acta. 493. S158–S159. 1 indexed citations
10.
Viggiani, Valentina, Gabriella d’Ettorre, Corrado De Vito, et al.. (2016). Protein induced by vitamin K absence or antagonist-II (PIVKA-II) specifically increased in Italian hepatocellular carcinoma patients. Scandinavian Journal of Gastroenterology. 51(10). 1257–1262. 17 indexed citations
11.
Granato, Teresa, Lucia Manganaro, Maria Grazia Porpora, et al.. (2015). Low 25-OH vitamin D levels at time of diagnosis and recurrence of ovarian cancer. Tumor Biology. 37(2). 2177–2181. 7 indexed citations
12.
Manganaro, Lucia, Valeria Vinci, Matteo Saldari, et al.. (2013). Serum HE4 levels combined with CE CT imaging improve the management of monitoring women affected by epithelial ovarian cancer. Oncology Reports. 30(5). 2481–2487. 22 indexed citations
13.
Viggiani, Valentina, et al.. (2013). Evaluation of a CLEIA automated assay system for the detection of a panel of tumor markers. Tumor Biology. 34(5). 3093–3100. 25 indexed citations
14.
Viggiani, Valentina, et al.. (2012). CLEIA CA125 evidences: good analytical performance avoiding “Hook effect”. Tumor Biology. 34(1). 387–393. 6 indexed citations
15.
Midulla, C, Lucia Manganaro, Flavia Longo, et al.. (2012). HE4 combined with MDCT imaging is a good marker in the evaluation of disease extension in advanced epithelial ovarian carcinoma. Tumor Biology. 33(5). 1291–1298. 21 indexed citations
16.
Anastasi, Emanuela, et al.. (2010). HE4: a new potential early biomarker for the recurrence of ovarian cancer. Tumor Biology. 31(2). 113–119. 141 indexed citations
17.
Anastasi, Emanuela, Teresa Granato, Valentina Viggiani, et al.. (2010). Ovarian tumor marker HE4 is differently expressed during the phases of the menstrual cycle in healthy young women. Tumor Biology. 31(5). 411–415. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angèle L.M. Oei Breakdown of academic impact, for papers by Andrea Puppo Breakdown of academic impact, for papers by Lirong Zhu Breakdown of academic impact, for papers by G. C. Torre Breakdown of academic impact, for papers by Takuhei Yokoyama Breakdown of academic impact, for papers by Viola Ghizzoni Breakdown of academic impact, for papers by Daniela Freitas Breakdown of academic impact, for papers by Alberto Villanueva Breakdown of academic impact, for papers by Rosemary Lord Breakdown of academic impact, for papers by Heng Cui
Rankless by CCL
2026